What's the Outlook for Moderna?
It's probably fair to say that no one in late 2019 would have foreseen the crazy ride that Moderna (NASDAQ: MRNA) has had so far this year. Global pandemics aren't all that easy to predict.
Moderna, once lauded for its biggest biotech IPO in history, is now celebrated as one of the leaders (some even think the leader) in developing a COVID-19 vaccine. Its shares have skyrocketed as a result. But what's the outlook for Moderna now?
Image source: Getty Images.
Source Fool.com


